Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops

This study has been completed.
Information provided by:
Santen Oy Identifier:
First received: January 8, 2008
Last updated: January 9, 2009
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)